scorecardresearch
Wednesday, July 23, 2025
TopicPharmaceutical industry

Topic: Pharmaceutical industry

Hundreds of colleges came up amid India’s pharma boom. Here’s why govt wants no more

India has barred new pharma colleges until 2021-22 to check poor-quality institutes looking to tap the industry’s growing popularity.

To fix quality of Indian drugs, Modi govt plans to tighten transportation & storage laws

Govt has stepped up the process after recent controversies raised question marks on the quality of drugs being manufactured in India.

US drug authority says some sleeping pills have serious side-effects, need warning on label

The drugs — eszopiclone (Lunesta), zaleplon (Sonata) and zolpidem (Ambien, Ambien CR, Edluar, Intermezzo, and Zolpimist) — are commonly prescribed in India too.

Sun pharma falls after report of fresh whistle-blower complaint

Shares of India’s largest drugmaker fell as much as 13.2 percent.

Stay on online sale of drugs to continue till rules are framed, says Delhi High Court

Pharmacies urged the court to remove the prohibition on online sale of drugs, saying they held licences and no medicines were sold illegally.

Discarded antibiotics make a comeback as fight against superbugs gathers pace

Move assumes significance as WHO has termed antibiotic resistance as one of the ‘biggest threats’ to global health.

Coming soon to China pharmacies, breakthrough drugs sold nowhere else

The nation's rapidly aging population with significant unmet medical needs has made it a big draw for global pharma. 

On Camera

Bihar mimics 19th-century American South. Citizenship is now weaponised to exclude voters

Disenfranchisement by institutional fiat is profoundly undemocratic. The effect of the ECI's new documentary process in Bihar will tilt the scales in favour of the BJP.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.